Immediate Impact

62 standout
Sub-graph 1 of 24

Citing Papers

Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
Extracellular vesicles in tumor immunity: mechanisms and novel insights
2025 Standout
2 intermediate papers

Works of Elisa Cerqui being referenced

Postremission therapy with repeated courses of high‐dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long‐term outcome in European leukemia net favorable and intermediate‐risk acute myeloid leukemia
2020
Postremission sequential monitoring of minimal residual disease by WT1 Q‐PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients
2015
and 1 more

Author Peers

Author Last Decade Papers Cites
Elisa Cerqui 197 80 58 90 18 278
Giuseppina Loglisci 188 129 57 50 22 273
Rebecca Howman 126 58 23 100 14 280
Joycelyn Sim 188 113 54 96 19 275
M.L. Martino 141 63 63 80 16 270
R. de Paz 132 45 56 39 21 274
R. M. Stone 188 59 42 126 13 296
Chiara Frairia 141 86 95 84 24 284
Nicole Raus 180 33 61 42 23 252
José Falantes 193 43 61 87 29 285
Stefano D’Ardìa 201 84 85 71 26 290

All Works

Loading papers...

Rankless by CCL
2026